$12.03
2.51% yesterday
Nasdaq, Jun 27, 10:15 pm CET
ISIN
US35803L1089
Symbol
KRRO

Frequency Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Frequency Therapeutics Inc Classifications & Recommendation:

Buy
94%
Hold
6%

Frequency Therapeutics Inc Price Target

Target Price $91.80
Price $12.03
Potential
Number of Estimates 11
11 Analysts have issued a price target Frequency Therapeutics Inc 2026 . The average Frequency Therapeutics Inc target price is $91.80. This is higher than the current stock price. The highest price target is
$189.00 1,471.07%
register free of charge
, the lowest is .
A rating was issued by 16 analysts: 15 Analysts recommend Frequency Therapeutics Inc to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Frequency Therapeutics Inc stock has an average upside potential 2026 of . Most analysts recommend the Frequency Therapeutics Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 2.27 3.75
65.15%
Net Margin -3,681.94% -2,438.66%
33.77%

12 Analysts have issued a sales forecast Frequency Therapeutics Inc 2025 . The average Frequency Therapeutics Inc sales estimate is

$3.7m
Unlock
. This is
22.22% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$8.1m 68.36%
Unlock
, the lowest is
$2.5m 48.15%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $2.3m
2025
$3.7m 65.15%
Unlock
2026
$1.3m 65.30%
Unlock
2027
$510k 60.80%
Unlock
2028
$3.2m 525.29%
Unlock
2029
$127m 3,877.11%
Unlock
2030
$492m 288.17%
Unlock
2031
$850m 72.61%
Unlock
2032
$1.7b 94.63%
Unlock

12 Frequency Therapeutics Inc Analysts have issued a net profit forecast 2025. The average Frequency Therapeutics Inc net profit estimate is

$-91.4m
Unlock
. This is
4.60% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-83.7m 4.23%
Unlock
, the lowest is
$-108m 23.18%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-83.6m 2.97%
2025
$-91.4m 9.39%
Unlock
2026
$-86.9m 4.97%
Unlock
2027
$-90.9m 4.60%
Unlock
2028
$-113m 24.77%
Unlock
2029
$-63.8m 43.75%
Unlock
2030
$149m 334.05%
Unlock
2031
$97.0m 35.06%
Unlock
2032
$332m 242.83%
Unlock

Net Margin

2024 -3,681.94%
2025
-2,438.66% 33.77%
Unlock
2026
-6,678.86% 173.87%
Unlock
2027
-17,822.22% 166.85%
Unlock
2028
-3,556.01% 80.05%
Unlock
2029
-50.29% 98.59%
Unlock
2030
30.33% 160.31%
Unlock
2031
11.41% 62.38%
Unlock
2032
20.10% 76.16%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -9.37 -9.74
7.50% 3.95%
P/E negative
EV/Sales negative

12 Analysts have issued a Frequency Therapeutics Inc forecast for earnings per share. The average Frequency Therapeutics Inc EPS is

$-9.74
Unlock
. This is
4.62% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-8.91 4.30%
Unlock
, the lowest is
$-11.47 23.20%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-9.37 7.50%
2025
$-9.74 3.95%
Unlock
2026
$-9.25 5.03%
Unlock
2027
$-9.68 4.65%
Unlock
2028
$-12.08 24.79%
Unlock
2029
$-6.79 43.79%
Unlock
2030
$15.90 334.17%
Unlock
2031
$10.33 35.03%
Unlock
2032
$35.40 242.69%
Unlock

P/E ratio

Current -1.29 63.04%
2025
-1.24 4.04%
Unlock
2026
-1.30 4.84%
Unlock
2027
-1.24 4.62%
Unlock
2028
-1.00 19.35%
Unlock
2029
-1.77 77.00%
Unlock
2030
0.76 142.94%
Unlock
2031
1.17 53.95%
Unlock
2032
0.34 70.94%
Unlock

Based on analysts' sales estimates for 2025, the Frequency Therapeutics Inc stock is valued at an EV/Sales of

-0.53
Unlock
and an P/S ratio of
30.13
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -0.41
2025
-0.53 28.80%
Unlock
2026
-1.52 188.18%
Unlock
2027
-3.88 155.10%
Unlock
2028
-0.62 84.01%
Unlock
2029
-0.02 97.49%
Unlock
2030
0.00 74.36%
Unlock
2031
0.00 42.50%
Unlock
2032
0.00 47.83%
Unlock

P/S ratio

Current
2025
30.13 28.57%
Unlock
2026
86.83 188.16%
Unlock
2027
221.51 155.10%
Unlock
2028
35.42 84.01%
Unlock
2029
0.89 97.49%
Unlock
2030
0.23 74.23%
Unlock
2031
0.13 42.09%
Unlock
2032
0.07 48.61%
Unlock

Current Frequency Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Chardan Capital
Locked
Locked
Locked May 13 2025
Oppenheimer
Locked
Locked
Locked May 13 2025
HC Wainwright & Co.
Locked
Locked
Locked May 08 2025
Cantor Fitzgerald
Locked
Locked
Locked Apr 29 2025
Chardan Capital
Locked
Locked
Locked Apr 16 2025
HC Wainwright & Co.
Locked
Locked
Locked Mar 20 2025
RBC Capital
Locked
Locked
Locked Mar 19 2025
Analyst Rating Date
Locked
Chardan Capital:
Locked
Locked
May 13 2025
Locked
Oppenheimer:
Locked
Locked
May 13 2025
Locked
HC Wainwright & Co.:
Locked
Locked
May 08 2025
Locked
Cantor Fitzgerald:
Locked
Locked
Apr 29 2025
Locked
Chardan Capital:
Locked
Locked
Apr 16 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 20 2025
Locked
RBC Capital:
Locked
Locked
Mar 19 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today